Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Research

Association between statin-associated myopathy and skeletal muscle damage

Markus G. Mohaupt, Richard H. Karas, Eduard B. Babiychuk, Verónica Sanchez-Freire, Katia Monastyrskaya, Lakshmanan Iyer, Hans Hoppeler, Fabio Breil and Annette Draeger
CMAJ July 07, 2009 181 (1-2) E11-E18; DOI: https://doi.org/10.1503/cmaj.081785
Markus G. Mohaupt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard H. Karas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduard B. Babiychuk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verónica Sanchez-Freire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katia Monastyrskaya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakshmanan Iyer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hans Hoppeler
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabio Breil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Draeger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Abstract

Background: Many patients taking statins often complain of muscle pain and weakness. The extent to which muscle pain reflects muscle injury is unknown.

Methods: We obtained biopsy samples from the vastus lateralis muscle of 83 patients. Of the 44 patients with clinically diagnosed statin-associated myopathy, 29 were currently taking a statin, and 15 had discontinued statin therapy before the biopsy (minimal duration of discontinuation 3 weeks). We also included 19 patients who were taking statins and had no myopathy, and 20 patients who had never taken statins and had no myopathy. We classified the muscles as injured if 2% or more of the muscle fibres in a biopsy sample showed damage. Using reverse transcriptase polymerase chain reaction, we evaluated the expression levels of candidate genes potentially related to myocyte injury.

Results: Muscle injury was observed in 25 (of 44) patients with myopathy and in 1 patient without myopathy. Only 1 patient with structural injury had a circulating level of creatine phosphokinase that was elevated more than 1950 U/L (10× the upper limit of normal). Expression of ryanodine receptor 3 was significantly upregulated in patients with biopsy evidence of structural damage (1.7, standard error of the mean 0.3).

Interpretation: Persistent myopathy in patients taking statins reflects structural muscle damage. A lack of elevated levels of circulating creatine phosphokinase does not rule out structural muscle injury. Upregulation of the expression of ryanodine receptor 3 is suggestive of an intracellular calcium leak.

View Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 181 (1-2)
CMAJ
Vol. 181, Issue 1-2
7 Jul 2009
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Association between statin-associated myopathy and skeletal muscle damage
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Association between statin-associated myopathy and skeletal muscle damage
Markus G. Mohaupt, Richard H. Karas, Eduard B. Babiychuk, Verónica Sanchez-Freire, Katia Monastyrskaya, Lakshmanan Iyer, Hans Hoppeler, Fabio Breil, Annette Draeger
CMAJ Jul 2009, 181 (1-2) E11-E18; DOI: 10.1503/cmaj.081785

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Association between statin-associated myopathy and skeletal muscle damage
Markus G. Mohaupt, Richard H. Karas, Eduard B. Babiychuk, Verónica Sanchez-Freire, Katia Monastyrskaya, Lakshmanan Iyer, Hans Hoppeler, Fabio Breil, Annette Draeger
CMAJ Jul 2009, 181 (1-2) E11-E18; DOI: 10.1503/cmaj.081785
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Interpretation
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • Dans ce numéro
  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • Etanercept-induced myositis: do we have to stop it? A surprising outcome
  • Authors' reply to Huffman and colleagues
  • Comparison of efficacy and adverse effect profile of high dose versus standard dose atorvastatin in acute ST elevation myocardial infarction patients
  • Google Scholar

More in this TOC Section

  • Self-harm among youth during the first 28 months of the COVID-19 pandemic in Ontario, Canada: a population-based study
  • Emergency department visits and hospital admissions for suicidal ideation, self-poisoning and self-harm among adolescents in Canada during the COVID-19 pandemic
  • Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
Show more Research

Similar Articles

Collections

  • Topics
    • Drugs: adverse reactions
    • Drugs: cardiovascular system

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire